WO2007079183A3 - Placental stem cell populations - Google Patents
Placental stem cell populations Download PDFInfo
- Publication number
- WO2007079183A3 WO2007079183A3 PCT/US2006/049491 US2006049491W WO2007079183A3 WO 2007079183 A3 WO2007079183 A3 WO 2007079183A3 US 2006049491 W US2006049491 W US 2006049491W WO 2007079183 A3 WO2007079183 A3 WO 2007079183A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- placental stem
- cell populations
- stem cell
- stem cells
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/42—Organic phosphate, e.g. beta glycerophosphate
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
Abstract
Priority Applications (36)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020207030297A KR20200123283A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
EP18196002.2A EP3486314B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
PL12150924T PL2471905T3 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020227015349A KR20220063304A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
ES06848281.9T ES2549111T3 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020177008335A KR101900809B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
EP06848281.9A EP1976977B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
NZ595786A NZ595786A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
PL12150928T PL2471906T3 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
PL06848281T PL1976977T3 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
PL12150934T PL2471907T3 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020217031368A KR20210122908A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020197025129A KR20190104428A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
EP12150919.4A EP2471904B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020187026653A KR20180105266A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020157020367A KR101722577B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
EP12150928.5A EP2471906B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
KR1020237019606A KR20230091193A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
AU2006332678A AU2006332678B2 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
CN200680053575.3A CN101395266B (en) | 2005-12-29 | 2006-12-28 | placental stem cell populations |
JP2008548745A JP5550235B2 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell population |
CA2635253A CA2635253C (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
NZ569562A NZ569562A (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations, CD200 |
PL12150919T PL2471904T3 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
EP12150924.4A EP2471905B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
EP12150934.3A EP2471907B1 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
IL192457A IL192457A0 (en) | 2005-12-29 | 2008-06-26 | Placental stem cell populations |
IL243876A IL243876B (en) | 2005-12-29 | 2012-11-20 | Adherent cd-90+ placental stem cell populations |
IL223156A IL223156A0 (en) | 2005-12-29 | 2012-11-20 | Placental stem cell populations |
IL223194A IL223194A (en) | 2005-12-29 | 2012-11-22 | Adherent placental stem cell populations |
AU2014201181A AU2014201181B2 (en) | 2005-12-29 | 2014-03-04 | Placental stem cell populations |
IL243876A IL243876A0 (en) | 2005-12-29 | 2016-01-31 | Placental stem cell populations |
AU2017248523A AU2017248523A1 (en) | 2005-12-29 | 2017-10-19 | Placental stem cell populations |
IL266958A IL266958A (en) | 2005-12-29 | 2019-05-28 | Placental stem cell populations |
AU2019268061A AU2019268061A1 (en) | 2005-12-29 | 2019-11-19 | Placental stem cell populations |
AU2022201955A AU2022201955A1 (en) | 2005-12-29 | 2022-03-22 | Placental stem cell populations |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75496805P | 2005-12-29 | 2005-12-29 | |
US60/754,968 | 2005-12-29 | ||
US84664106P | 2006-09-22 | 2006-09-22 | |
US60/846,641 | 2006-09-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007079183A2 WO2007079183A2 (en) | 2007-07-12 |
WO2007079183A3 true WO2007079183A3 (en) | 2007-11-15 |
Family
ID=38069162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/049491 WO2007079183A2 (en) | 2005-12-29 | 2006-12-28 | Placental stem cell populations |
Country Status (18)
Country | Link |
---|---|
US (7) | US8057788B2 (en) |
EP (7) | EP3486314B1 (en) |
JP (2) | JP5550235B2 (en) |
KR (9) | KR20210122908A (en) |
CN (5) | CN103525758B (en) |
AU (1) | AU2006332678B2 (en) |
CA (2) | CA2635253C (en) |
DK (5) | DK2471906T3 (en) |
ES (6) | ES2703502T3 (en) |
HK (1) | HK1184817A1 (en) |
IL (6) | IL192457A0 (en) |
MX (4) | MX2018012512A (en) |
NZ (4) | NZ622377A (en) |
PE (1) | PE20080146A1 (en) |
PL (6) | PL2471906T3 (en) |
PT (5) | PT2471907T (en) |
WO (1) | WO2007079183A2 (en) |
ZA (2) | ZA201004182B (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101942413A (en) * | 2009-07-07 | 2011-01-12 | 翁炳焕 | Birth defect cell bank and construction method thereof |
US8691217B2 (en) | 2005-12-29 | 2014-04-08 | Anthrogenesis Corporation | Placental stem cell populations |
US8889411B2 (en) | 2002-04-12 | 2014-11-18 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US8895256B2 (en) | 2005-10-13 | 2014-11-25 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US8916146B2 (en) | 2007-02-12 | 2014-12-23 | Anthrogenesis Corporation | Treatment of inflammatory diseases using placental stem cells |
US8926964B2 (en) | 2010-07-13 | 2015-01-06 | Anthrogenesis Corporation | Methods of generating natural killer cells |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
US9121007B2 (en) | 2010-01-26 | 2015-09-01 | Anthrogenesis Corporatin | Treatment of bone-related cancers using placental stem cells |
US9149569B2 (en) | 2000-12-06 | 2015-10-06 | Anthrogenesis Corporation | Treatment of diseases or disorders using placental stem cells |
US9216200B2 (en) | 2007-09-28 | 2015-12-22 | Anthrogenesis Corporation | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
US9255248B2 (en) | 2009-07-02 | 2016-02-09 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
US9254302B2 (en) | 2010-04-07 | 2016-02-09 | Anthrogenesis Corporation | Angiogenesis using placental stem cells |
US9339520B2 (en) | 2006-10-23 | 2016-05-17 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
US9598669B2 (en) | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
US11590173B2 (en) | 2010-02-18 | 2023-02-28 | Osiris Therapeutics, Inc. | Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
Families Citing this family (166)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
KR101012952B1 (en) | 2001-02-14 | 2011-02-08 | 안트로제네시스 코포레이션 | Post-partum mammalian placenta, its use and placental stem cells therefrom |
KR101042448B1 (en) * | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
US8491883B2 (en) | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
EP1641913B1 (en) | 2003-06-27 | 2016-01-06 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
US9572840B2 (en) | 2003-06-27 | 2017-02-21 | DePuy Synthes Products, Inc. | Regeneration and repair of neural tissue using postpartum-derived cells |
US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
GB0321337D0 (en) * | 2003-09-11 | 2003-10-15 | Massone Mobile Advertising Sys | Method and system for distributing advertisements |
WO2005055929A2 (en) * | 2003-12-02 | 2005-06-23 | Celgene Corporation | Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
US20050176139A1 (en) * | 2004-01-12 | 2005-08-11 | Yao-Chang Chen | Placental stem cell and methods thereof |
ZA200607800B (en) * | 2004-03-26 | 2009-02-25 | Celgene Corp | System and methods for providing a stem cell bank |
PL1831356T3 (en) * | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
CA2592435C (en) | 2004-12-23 | 2017-03-28 | Ethicon, Incorporated | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
US20100028312A1 (en) * | 2005-03-24 | 2010-02-04 | Caritas St. Elizabeth Medical Center of Boston Inc | Stably transformed bone marrow-derived cells and uses thereof |
ZA200803929B (en) * | 2005-10-13 | 2009-08-26 | Anthrogenesis Corp | Production of oligodendrocytes from placenta-derived stem cells |
PL1971681T3 (en) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
WO2007073552A1 (en) | 2005-12-19 | 2007-06-28 | Ethicon, Inc. | In vitro expansion of postpartum derived cells in roller bottles |
US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
AU2006332679A1 (en) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
US9944900B2 (en) * | 2006-01-18 | 2018-04-17 | Hemacell Perfusion | Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells |
CN101483998A (en) * | 2006-05-11 | 2009-07-15 | 武部直子 | Methods for collecting and using placenta cord blood stem cells |
US20080050814A1 (en) * | 2006-06-05 | 2008-02-28 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
US8372437B2 (en) | 2006-08-17 | 2013-02-12 | Mimedx Group, Inc. | Placental tissue grafts |
US8506949B2 (en) | 2007-01-17 | 2013-08-13 | Stemnion, Inc. | Methods for modulating inflammatory and/or immune responses |
US8221741B2 (en) | 2007-01-17 | 2012-07-17 | Marshall Vivienne S | Methods for modulating inflammatory and/or immune responses |
EP2129775A1 (en) * | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
WO2008109816A1 (en) * | 2007-03-08 | 2008-09-12 | Hemacell Perfusion, Inc. | Method for isolation of afterbirth derived cells |
US20100172830A1 (en) * | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
US8273526B2 (en) | 2007-06-18 | 2012-09-25 | Children's Hospital & Research Center At Oakland | Method of isolating stem and progenitor cells from placenta |
EP2014294A1 (en) * | 2007-07-13 | 2009-01-14 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of CD200 as a mesenchymal stem cells marker |
WO2009014668A2 (en) * | 2007-07-24 | 2009-01-29 | Stemnion, Inc. | Methods for promoting hair growth |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
CA2736663C (en) | 2007-09-07 | 2018-01-02 | Surgical Biologics, Llc. | Placental tissue grafts and improved methods of preparing and using the same |
US20090074731A1 (en) * | 2007-09-13 | 2009-03-19 | Librach Clifford L | Method of isolation and use of cells derived from first trimester umbilical cord tissue |
US10925903B2 (en) | 2007-09-13 | 2021-02-23 | Reprobiogen Inc. | Use of cells derived from first trimester umbilical cord tissue |
EP2591789B2 (en) | 2007-09-19 | 2022-07-20 | Pluristem Ltd. | Adherent cells from adipose or placenta tissues and use thereof in therapy |
KR101644659B1 (en) * | 2007-09-26 | 2016-08-01 | 안트로제네시스 코포레이션 | Angiogenic cells from human placental perfusate |
US8034329B2 (en) | 2007-10-05 | 2011-10-11 | Advanced Technologies And Regenerative Medicine, Llc | Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells |
KR20160040739A (en) * | 2007-11-07 | 2016-04-14 | 안트로제네시스 코포레이션 | Use of umbilical cord blood in the treatment of premature birth complications |
CN101765657A (en) * | 2007-11-09 | 2010-06-30 | Rnl生物技术株式会社 | Method for isolating and culturing adult stem cells derived from human amniotic epithelium |
US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
US20110027795A1 (en) * | 2008-02-18 | 2011-02-03 | Genetic Technologies Limited | Cell processing and/or enrichment methods |
US9458431B2 (en) | 2008-03-17 | 2016-10-04 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
WO2009116951A2 (en) | 2008-03-17 | 2009-09-24 | Agency For Science, Technology And Research | Microcarriers for stem cell culture |
US20120028352A1 (en) * | 2008-03-17 | 2012-02-02 | Agency For Science, Technology And Research | Microcarriers for Stem Cell Culture |
US8497122B2 (en) | 2008-04-11 | 2013-07-30 | Washington University | Biomarkers for Niemann-pick C disease and related disorders |
WO2009131568A1 (en) * | 2008-04-21 | 2009-10-29 | Cythera, Inc. | Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells |
BRPI0909541A2 (en) * | 2008-05-27 | 2016-10-11 | Pluristem Ltd | '' method for treating inflammatory bowel disease '' |
KR20110050521A (en) | 2008-08-20 | 2011-05-13 | 안트로제네시스 코포레이션 | Improved cell composition and methods of making the same |
KR101903049B1 (en) * | 2008-08-20 | 2018-11-07 | 안트로제네시스 코포레이션 | Treatment of stroke using isolated placental cells |
KR20110050688A (en) | 2008-08-22 | 2011-05-16 | 안트로제네시스 코포레이션 | Methods and compositions for treatment of bone defects with placental cell populations |
CN105708862B (en) * | 2008-09-02 | 2020-11-06 | 普拉里斯坦有限公司 | Adherent cells from placental tissue and their use in therapy |
WO2010026574A2 (en) * | 2008-09-02 | 2010-03-11 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
WO2010026573A1 (en) * | 2008-09-02 | 2010-03-11 | Pluristem Ltd. | Methods of selection of cells for transplantation |
WO2010040262A1 (en) * | 2008-10-10 | 2010-04-15 | 深圳市嘉天源生物科技有限公司 | Methods for isolating animal embryonic mesenchymal stem cells and extracting secretion substance thereof |
EP2248887A4 (en) * | 2008-10-17 | 2013-04-17 | Affiliated Hospital Of Ningxia Medical University | A method for constructing human placental mesenchymal cells library which is suitable for clinical application |
AU2009316541B2 (en) * | 2008-11-19 | 2015-08-06 | Celularity Inc. | Amnion derived adherent cells |
ES2731340T3 (en) * | 2008-11-21 | 2019-11-15 | Celularity Inc | Treatment of diseases, disorders or lung conditions using placental cells |
US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
US10557116B2 (en) | 2008-12-19 | 2020-02-11 | DePuy Synthes Products, Inc. | Treatment of lung and pulmonary diseases and disorders |
US8771677B2 (en) | 2008-12-29 | 2014-07-08 | Vladimir B Serikov | Colony-forming unit cell of human chorion and method to obtain and use thereof |
ES2713524T3 (en) | 2009-03-25 | 2019-05-22 | Celularity Inc | Tumor suppression using intermediate natural cytolytic lymphocytes obtained from human placenta and immunomodulatory compounds |
AU2010229651B2 (en) | 2009-03-26 | 2014-05-08 | Advanced Technologies And Regenerative Medicine, Llc | Human umbilical cord tissue cells as therapy for Alzheimer' s disease |
CA2795268A1 (en) | 2009-04-21 | 2010-10-28 | Genetic Technologies Limited | Methods for obtaining fetal genetic material |
US20100323446A1 (en) | 2009-06-05 | 2010-12-23 | Jill Renee Barnett | Method of collecting placental cells |
US8796315B2 (en) | 2009-06-25 | 2014-08-05 | Darlene E. McCord | Methods for improved wound closure employing olivamine and human umbilical vein endothelial cells |
SG177467A1 (en) * | 2009-07-23 | 2012-02-28 | Agency Science Tech & Res | Pre-natal mesenchymal stem cells |
EP2491114B8 (en) * | 2009-10-23 | 2017-01-25 | Amorcyte, Inc. | Compositions and uses for treating progressive myocardial injury due to a vascular insufficiency |
AU2013203479B2 (en) * | 2010-04-07 | 2016-05-19 | Celularity Inc. | Angiogenesis using placental stem cells |
WO2011127113A1 (en) * | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
KR101211913B1 (en) * | 2010-07-16 | 2012-12-13 | 주식회사 알앤엘바이오 | Medium for Culturing Mesenchymal Stem Cells Derived from Amnion and Method for Culturing Mesenchymal Stem Cells Derived from Amnion Using thereof |
KR20200116546A (en) * | 2010-12-17 | 2020-10-12 | 안트로제네시스 코포레이션 | Treatment of spinal cord injury and traumatic brain injury using placental stem cells |
US8574899B2 (en) | 2010-12-22 | 2013-11-05 | Vladimir B Serikov | Methods for augmentation collection of placental hematopoietic stem cells and uses thereof |
AR084754A1 (en) | 2010-12-30 | 2013-06-05 | Anthrogenesis Corp | COMPOSITIONS THAT INCLUDE MOTHER PLACENTA CELLS AND PLASMA RICH IN PLATES, AND THEIR METHODS OF USE |
US20120171180A1 (en) | 2010-12-30 | 2012-07-05 | Sascha Abramson | Compositions comprising amnion derived adherent cells and platelet-rich plasma |
US20140017209A1 (en) * | 2011-03-22 | 2014-01-16 | Pluristem Ltd. | Methods for treating radiation or chemical injury |
EP2689008B1 (en) * | 2011-03-22 | 2017-09-27 | Pluristem Ltd. | Methods for treating radiation or chemical injury |
US20120276215A1 (en) * | 2011-04-26 | 2012-11-01 | Riordan Neil H | Therapeutic Conditioned Media |
PL2714059T3 (en) * | 2011-06-01 | 2019-04-30 | Celularity Inc | Treatment of pain using placental stem cells |
JP2014520857A (en) * | 2011-07-15 | 2014-08-25 | アントフロゲネシス コーポレーション | Treatment of radiation damage using amnion-derived adherent cells |
CN102676451B (en) * | 2011-09-05 | 2014-04-16 | 博雅干细胞科技有限公司 | Method for separating mesenchymal stem cells from placenta |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
US20140242038A1 (en) * | 2011-10-11 | 2014-08-28 | The Trustees Of Columbia University In The City Of New York | Method for generating beta cells |
WO2013067038A1 (en) * | 2011-11-01 | 2013-05-10 | Neostem, Inc. | Adult mesenchymal stem cell (msc) compositions and methods for preparing the same |
SG11201403465PA (en) | 2011-12-23 | 2014-10-30 | Atrm Llc | Detection of human umbilical cord tissue-derived cells |
US11311367B2 (en) | 2012-01-31 | 2022-04-26 | Wake Forest University Health Sciences | Tissue-engineered gut-sphincter complexes and methods of making the same |
ES2666576T3 (en) | 2012-02-23 | 2018-05-07 | Anthrogenesis Corporation | Identification of antitumor compounds using placenta |
AU2013230653A1 (en) * | 2012-03-06 | 2014-10-23 | Sct&B Inc. | Placental stem cells, methods for isolating same and use thereof |
KR101422559B1 (en) * | 2012-03-09 | 2014-07-24 | 창원대학교 산학협력단 | Culture medium of adipose-derived stem cell, method for preparing the same, and composition for promoting hair growth comprising the same |
KR101523040B1 (en) * | 2012-06-26 | 2015-05-26 | 라정찬 | Method for Preparing High Concentration of Stem Cells |
US9657290B2 (en) | 2012-07-03 | 2017-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Scalable bio-element analysis |
RU2015108761A (en) | 2012-08-13 | 2016-10-10 | Антродженезис Корпорейшн | NATURAL KILLER CELLS AND THEIR APPLICATION |
KR101532556B1 (en) * | 2012-09-03 | 2015-06-30 | 메디포스트(주) | Method for culturing mesenchymal stem cells |
RU2733838C2 (en) | 2012-09-04 | 2020-10-07 | Антродженезис Корпорейшн | Methods for producing tissues |
EP2892996B1 (en) * | 2012-09-07 | 2019-08-14 | BioLamina AB | Stem cell bank |
EP2909314B1 (en) | 2012-10-19 | 2020-12-02 | Celularity, Inc. | Treatment of pain using amnion derived adherent cells |
US9144555B2 (en) | 2012-11-30 | 2015-09-29 | Darlene E. McCord | Hydroxytyrosol and oleuropein compositions for induction of DNA damage, cell death and LSD1 inhibition |
RU2019101641A (en) | 2012-12-07 | 2019-03-20 | Антродженезис Корпорейшн | TREATMENT OF INJURIES OF THE ORAL CAVITY BY USING THE EXTRACELLULAR MATRIX OF THE PLACENTA |
CA2895106C (en) | 2012-12-14 | 2023-01-24 | Anthrogenesis Corporation | Anoikis resistant placental stem cells and uses thereof |
AU2013204922B2 (en) | 2012-12-20 | 2015-05-14 | Celgene Corporation | Chimeric antigen receptors |
US9763983B2 (en) | 2013-02-05 | 2017-09-19 | Anthrogenesis Corporation | Natural killer cells from placenta |
WO2014129792A1 (en) * | 2013-02-20 | 2014-08-28 | 사회복지법인 삼성생명공익재단 | Composition for treating inflammatory brain diseases which includes stem cell as active ingredient |
US20160030488A1 (en) | 2013-03-14 | 2016-02-04 | Antrhogenesis Corporation | Use of placental stem cells in treatment of acute kidney injury |
DK2970883T3 (en) | 2013-03-14 | 2021-08-09 | Celularity Inc | Improved placenta stem cells and use thereof |
EP2970372B1 (en) | 2013-03-15 | 2020-09-30 | Celgene Corporation | Modified t lymphocytes |
WO2014145653A2 (en) | 2013-03-15 | 2014-09-18 | Wake Forest University Health Sciences | Neural progenitor cell differentiation |
JP6123018B2 (en) * | 2013-03-15 | 2017-04-26 | ニューテック メディカル インコーポレイテッド | Formulations derived from placental substances and methods for producing and using the same |
NO2975611T3 (en) | 2013-03-15 | 2018-06-09 | ||
US9795639B1 (en) | 2013-03-16 | 2017-10-24 | BioDlogics, LLC | Methods for the treatment of erectile dysfunction by human birth tissue material compostion |
CN103173405B (en) * | 2013-03-21 | 2017-11-07 | 北京京蒙高科干细胞技术有限公司 | A kind of simple separation of Human plactnta myofibroblast mother cell and authentication method |
KR101583569B1 (en) * | 2013-05-15 | 2016-01-08 | 라정찬 | Composition for Intravenous Administration Comprising Stem Cells |
WO2014209856A1 (en) | 2013-06-24 | 2014-12-31 | Anthrogenesis Corporation | Extracellular matrix composition beads for cell culture |
JP2016537362A (en) | 2013-11-15 | 2016-12-01 | アントフロゲネシス コーポレーション | Human placental perfusate cells, compositions comprising subpopulations thereof, and uses thereof |
CN106255747B (en) * | 2014-01-08 | 2019-11-26 | 社会福祉法人三星生命公益财团 | Stem cell from trophoderm basal layer and the cellular therapeutic agent comprising it |
JP6486948B2 (en) * | 2014-01-08 | 2019-03-20 | サムスン ライフ パブリック ウェルフェア ファウンデーション | Stem cells derived from pure trophoblast layer and cell therapeutic agent containing the same |
CN103756965B (en) * | 2014-01-27 | 2016-04-06 | 山东省齐鲁干细胞工程有限公司 | A kind of method of lavation hemopoietic stem cell from placenta |
WO2015164233A1 (en) * | 2014-04-21 | 2015-10-29 | Anthrogenesis Corporation | Treatment of conditions and complications in infants |
WO2016007827A1 (en) | 2014-07-11 | 2016-01-14 | Anthrogenesis Corporation | Methods of improving vector transduction efficiency into t lymphocytes |
SG11201701111SA (en) | 2014-08-12 | 2017-03-30 | Anthrogenesis Corp | Car-t lymphocytes engineered to home to lymph node b cell zone, skin, or gastrointestinal tract |
CA2964114A1 (en) | 2014-10-09 | 2016-04-14 | Anthrogenesis Corporation | Placenta-derived adherent cell exosomes and uses thereof |
WO2016068616A1 (en) * | 2014-10-29 | 2016-05-06 | 차의과학대학교 산학협력단 | Placenta-derived cells excreting c3 or c1r complement and composition containing same |
JP6920997B2 (en) | 2015-02-22 | 2021-08-18 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Microscreening equipment, processes, and products |
WO2016149492A1 (en) * | 2015-03-18 | 2016-09-22 | Anthrogenesis Corporation | Methods of banking placental tissue and cells |
US10531957B2 (en) | 2015-05-21 | 2020-01-14 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
BR112017025586A2 (en) * | 2015-05-28 | 2018-08-07 | Celularity Inc | Placenta-derived stem cells to restore regenerative mechanism, correct proteomic defects and prolong shelf life |
WO2017039251A1 (en) * | 2015-08-28 | 2017-03-09 | 주식회사 차바이오텍 | Enhanced postnatal adherent cell, and use for same |
EP3349771A4 (en) | 2015-09-15 | 2019-04-24 | Celularity, Inc. | Treatment of diabetic peripheral neuropathy using placental cells |
EP3356515A4 (en) * | 2015-09-29 | 2019-06-12 | Celularity, Inc. | Cell potency assay |
US20190015190A1 (en) | 2015-12-30 | 2019-01-17 | Wake Forest University Health Sciences | Tissue-engineered gut-sphincter complexes and methods of making the same |
WO2017160986A1 (en) * | 2016-03-16 | 2017-09-21 | Cell Medicine, Inc. | Mesenchymal stem cells with enhanced efficacy |
WO2018053485A1 (en) * | 2016-09-19 | 2018-03-22 | The Board Of Trustees Of The Leland Stanford Junior University | Micro-screening and sorting apparatus, process, and products |
CN110198786A (en) | 2016-11-14 | 2019-09-03 | 浩康生物系统公司 | Method and apparatus for sorting target particles |
EP3548051A1 (en) | 2016-12-05 | 2019-10-09 | Celularity, Inc. | Treatment of lymphedema and related conditions using placental adherent cells |
US10433112B2 (en) * | 2017-02-22 | 2019-10-01 | Middle Chart, LLC | Methods and apparatus for orienteering |
US10300090B2 (en) | 2017-03-15 | 2019-05-28 | Orca Biosystems, Inc. | Compositions of hematopoietic stem cell transplants |
EP3608400A4 (en) * | 2017-04-03 | 2021-01-06 | Kaneka Corporation | Cell population including mesenchymal stem cells, production method therefor, and pharmaceutical composition |
CN107586757A (en) * | 2017-11-01 | 2018-01-16 | 天津昂赛细胞基因工程有限公司 | One boar Mesenchymal stem cell nutrient solution and preparation method thereof |
US10142452B1 (en) * | 2018-05-29 | 2018-11-27 | Guangzhou Zhijing Technology Co., Ltd | Mobile terminal unlock method |
EA202191508A1 (en) | 2018-11-30 | 2021-09-21 | Селулэрити Инк. | REPRODUCTION OF NATURAL KILLER CELLS AND ILC3 CELLS USING NEW AROMATIC COMPOUNDS |
EP3883586A4 (en) * | 2019-03-27 | 2022-09-07 | Pluristem Ltd. | Methods and compositions for aesthetic and cosmetic treatment and stimulating hair growth |
CN109908351B (en) * | 2019-04-08 | 2021-04-06 | 中南大学 | Application of circ _ ADARB1 in preparation of nasopharyngeal carcinoma treatment preparation and treatment preparation |
WO2020252464A1 (en) | 2019-06-14 | 2020-12-17 | Celularity Inc. | Populations of natural killer cells for treating cancers |
WO2021003254A1 (en) * | 2019-07-01 | 2021-01-07 | Auxocell Laboratories, Inc. | Cryopreservation medium comprising a tissue extract |
CN110468099B (en) * | 2019-07-19 | 2023-08-15 | 海门生原干细胞科技有限公司 | Bone marrow mesenchymal stem cell culture medium and application thereof |
US20220273716A1 (en) | 2019-07-25 | 2022-09-01 | Celularity Inc. | Populations of natural killer cells comprising a cd38 chimeric antigen receptor |
US20230355759A1 (en) | 2019-07-31 | 2023-11-09 | Celularity Inc. | Populations of natural killer cells comprising a cleavage resistant cd16 |
CN110592005A (en) * | 2019-08-14 | 2019-12-20 | 广州乾晖生物科技有限公司 | Method for separating mesenchymal stem cells |
WO2021113849A1 (en) | 2019-12-05 | 2021-06-10 | Celularity Inc. | Her2+ cancer treatment with populations of natural killer cells comprising a cleavage resistant cd16 |
US20220000919A1 (en) | 2020-01-29 | 2022-01-06 | Celularity Inc. | Placental derived natural killer cells for treatment of coronavirus infections |
US20230210909A1 (en) | 2020-05-08 | 2023-07-06 | Celularity Inc. | Placenta-derived adherent (pda) stem cell for the treatment of adults with sars-cov-2 related acute respiratory failure and ards (covid-19) |
WO2021257073A1 (en) * | 2020-06-17 | 2021-12-23 | Joy Kong | Method for producing mesenchymal stem cells from neonatal stem cells |
CN111956787A (en) * | 2020-07-06 | 2020-11-20 | 沃森克里克(北京)生物科技有限公司 | Hair growth promoter and hair growth promoter and application thereof |
US20240002788A1 (en) * | 2020-12-03 | 2024-01-04 | VityleBio, Inc. | Regenerative Tissue Extract from Non-Human Mammalian Placenta |
CN112592885B (en) * | 2020-12-23 | 2022-06-17 | 山东华领奥源生物科技有限公司 | Separation culture method of placenta sub-totipotent stem cells |
WO2023278628A1 (en) | 2021-06-29 | 2023-01-05 | Celularity Inc. | Human placental hematopoietic stem cell derived natural killer cells in acute myeloid leukemia (aml) remission with minimal residual disease (mrd) or relapsed/refractory aml |
WO2023010123A1 (en) | 2021-07-29 | 2023-02-02 | Celularity Inc. | Placenta-dervied nk cells as a senolytic for therapeutic and other uses |
WO2023137344A1 (en) | 2022-01-11 | 2023-07-20 | Celularity Inc. | Cleavage resistant cd16 constructs and uses thereof |
CN116144583B (en) * | 2023-04-19 | 2023-08-25 | 北京雪颜博润生物科技有限公司 | Method for obtaining human placenta embryo-derived stem cells and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1407088A (en) * | 2001-09-06 | 2003-04-02 | 周胜利 | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
CN1786154A (en) * | 2005-10-18 | 2006-06-14 | 天津昂赛细胞基因工程有限公司 | Human placenta, umbilical cord mesenchyma stemcell stock and its construction method |
WO2006111706A1 (en) * | 2005-04-16 | 2006-10-26 | Axordia Limited | Cytotrophoblast stem cell |
WO2007047468A2 (en) * | 2005-10-13 | 2007-04-26 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
Family Cites Families (332)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
US3372581A (en) | 1965-04-27 | 1968-03-12 | Tell Sven Axel | Dynamometer |
US4829000A (en) * | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US4798824A (en) | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
US5266480A (en) | 1986-04-18 | 1993-11-30 | Advanced Tissue Sciences, Inc. | Three-dimensional skin culture system |
US5902741A (en) | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5744347A (en) | 1987-01-16 | 1998-04-28 | Ohio University Edison Biotechnology Institute | Yolk sac stem cells and their uses |
NZ226750A (en) | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
US5192553A (en) | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
US5004681B1 (en) | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
GB8803697D0 (en) | 1988-02-17 | 1988-03-16 | Deltanine Research Ltd | Clinical developments using amniotic membrane cells |
US5284766A (en) | 1989-02-10 | 1994-02-08 | Kao Corporation | Bed material for cell culture |
FR2646438B1 (en) | 1989-03-20 | 2007-11-02 | Pasteur Institut | A METHOD FOR SPECIFIC REPLACEMENT OF A COPY OF A GENE PRESENT IN THE RECEIVER GENOME BY INTEGRATION OF A GENE DIFFERENT FROM THAT OR INTEGRATION |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5763266A (en) | 1989-06-15 | 1998-06-09 | The Regents Of The University Of Michigan | Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5635386A (en) | 1989-06-15 | 1997-06-03 | The Regents Of The University Of Michigan | Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture |
EP0437576B1 (en) | 1989-07-25 | 2002-07-03 | Cell Genesys, Inc. | Homologous recombination for universal donor cells and chimeric mammalian hosts |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
ES2127458T3 (en) | 1989-11-06 | 1999-04-16 | Cell Genesys Inc | PROTEIN PRODUCTION USING HOMOLOGICAL RECOMBINATION. |
US5272071A (en) | 1989-12-22 | 1993-12-21 | Applied Research Systems Ars Holding N.V. | Method for the modification of the expression characteristics of an endogenous gene of a given cell line |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5635387A (en) | 1990-04-23 | 1997-06-03 | Cellpro, Inc. | Methods and device for culturing human hematopoietic cells and their precursors |
US6326198B1 (en) | 1990-06-14 | 2001-12-04 | Regents Of The University Of Michigan | Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5226914A (en) | 1990-11-16 | 1993-07-13 | Caplan Arnold I | Method for treating connective tissue disorders |
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5837539A (en) | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5811094A (en) | 1990-11-16 | 1998-09-22 | Osiris Therapeutics, Inc. | Connective tissue regeneration using human mesenchymal stem cell preparations |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
US5744361A (en) * | 1991-04-09 | 1998-04-28 | Indiana University | Expansion of human hematopoietic progenitor cells in a liquid medium |
US5750376A (en) | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
WO1993003139A1 (en) | 1991-08-08 | 1993-02-18 | Kao Corporation | Cell culture support, production thereof, and production of cell cluster using same |
EP0529751A1 (en) | 1991-08-09 | 1993-03-03 | W.R. Grace & Co.-Conn. | Cell culture substrate, test material for cell culture and preparations thereof |
AU2515992A (en) | 1991-08-20 | 1993-03-16 | Genpharm International, Inc. | Gene targeting in animal cells using isogenic dna constructs |
US5356373A (en) | 1991-11-15 | 1994-10-18 | Miles Inc. | Method and apparatus for autologous transfusions in premature infants |
AU679436B2 (en) | 1991-12-23 | 1997-07-03 | British Bio-Technology Limited | Stem cell inhibiting proteins |
EP0590156A4 (en) | 1992-03-31 | 1994-07-13 | Toray Industries | Novel, physiologically active protein and hemopoietic stem cell growth promoter |
US5552267A (en) | 1992-04-03 | 1996-09-03 | The Trustees Of Columbia University In The City Of New York | Solution for prolonged organ preservation |
US5460964A (en) | 1992-04-03 | 1995-10-24 | Regents Of The University Of Minnesota | Method for culturing hematopoietic cells |
WO1994000484A1 (en) | 1992-06-22 | 1994-01-06 | Young Henry E | Scar inhibitory factor and use thereof |
US5849553A (en) | 1992-07-27 | 1998-12-15 | California Institute Of Technology | Mammalian multipotent neural stem cells |
US5672499A (en) | 1992-07-27 | 1997-09-30 | California Institute Of Technology | Immoralized neural crest stem cells and methods of making |
US5672346A (en) | 1992-07-27 | 1997-09-30 | Indiana University Foundation | Human stem cell compositions and methods |
EP0669974A1 (en) | 1992-11-16 | 1995-09-06 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Pluripotential quiescent stem cell population |
US5772992A (en) | 1992-11-24 | 1998-06-30 | G.D. Searle & Co. | Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors |
US5654186A (en) | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
AU694111B2 (en) * | 1993-03-31 | 1998-07-16 | Pro-Neuron, Inc. | Inhibitor of stem cell proliferation and uses thereof |
GB9308271D0 (en) | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
IL107483A0 (en) | 1993-11-03 | 1994-02-27 | Yeda Res & Dev | Bone marrow transplantation |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
US6001654A (en) | 1994-01-28 | 1999-12-14 | California Institute Of Technology | Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US5580724A (en) | 1994-03-25 | 1996-12-03 | Board Of Regents, The University Of Texas System | Differential expansion of fetal stem cells in maternal circulation for use in prenatal genetic analysis |
PT952792E (en) * | 1994-06-06 | 2003-12-31 | Osiris Therapeutics Inc | BIOMATRIZ FOR REGENERATION OF FABRICS |
US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
DE4422667A1 (en) | 1994-06-30 | 1996-01-04 | Boehringer Ingelheim Int | Process for the production and cultivation of hematopoietic progenitor cells |
US6103522A (en) * | 1994-07-20 | 2000-08-15 | Fred Hutchinson Cancer Research Center | Human marrow stromal cell lines which sustain hematopoiesis |
US5516532A (en) * | 1994-08-05 | 1996-05-14 | Children's Medical Center Corporation | Injectable non-immunogenic cartilage and bone preparation |
US5840502A (en) | 1994-08-31 | 1998-11-24 | Activated Cell Therapy, Inc. | Methods for enriching specific cell-types by density gradient centrifugation |
US5827742A (en) | 1994-09-01 | 1998-10-27 | Beth Israel Deaconess Medical Center, Inc. | Method of selecting pluripotent hematopioetic progenitor cells |
US5665557A (en) | 1994-11-14 | 1997-09-09 | Systemix, Inc. | Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof |
US5914268A (en) | 1994-11-21 | 1999-06-22 | National Jewish Center For Immunology & Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5874301A (en) | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5789147A (en) | 1994-12-05 | 1998-08-04 | New York Blood Center, Inc. | Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood |
US5736396A (en) | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US7410773B2 (en) | 1995-02-02 | 2008-08-12 | Ghazi Jaswinder Dhoot | Method of preparing an undifferentiated cell |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US6974571B2 (en) | 1995-03-28 | 2005-12-13 | Thomas Jefferson University | Isolated stromal cells and methods of using the same |
US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
EP0822955B1 (en) | 1995-04-27 | 1999-03-10 | The Procter & Gamble Company | Carrier substrate treated with high internal water phase inverse emulsion made with an organopolysiloxane-polyoxyalkylene emulsifier |
US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5908782A (en) | 1995-06-05 | 1999-06-01 | Osiris Therapeutics, Inc. | Chemically defined medium for human mesenchymal stem cells |
US5830708A (en) | 1995-06-06 | 1998-11-03 | Advanced Tissue Sciences, Inc. | Methods for production of a naturally secreted extracellular matrix |
WO1996040875A1 (en) | 1995-06-07 | 1996-12-19 | Novartis Ag | Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein |
US5877299A (en) * | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US6306575B1 (en) | 1995-06-16 | 2001-10-23 | Stemcell Technologies, Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5654381A (en) | 1995-06-16 | 1997-08-05 | Massachusetts Institute Of Technology | Functionalized polyester graft copolymers |
US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
US5800539A (en) | 1995-11-08 | 1998-09-01 | Emory University | Method of allogeneic hematopoietic stem cell transplantation without graft failure or graft vs. host disease |
US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
US5922597A (en) | 1995-11-14 | 1999-07-13 | Regents Of The University Of Minnesota | Ex vivo culture of stem cells |
WO1997018299A1 (en) | 1995-11-16 | 1997-05-22 | Case Western Reserve University | In vitro chondrogenic induction of human mesenchymal stem cells |
ATE319827T1 (en) * | 1995-11-17 | 2006-03-15 | Asahi Chemical Ind | POLYPEPTIDE THAT SUPPRESSES DIFFERENTIATION |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
EP0906415B1 (en) * | 1996-04-19 | 2009-08-19 | Osiris Therapeutics, Inc. | Regeneration and augmentation of bone using mesenchymal stem cells |
US6455678B1 (en) | 1996-04-26 | 2002-09-24 | Amcell Corporation | Human hematopoietic stem and progenitor cell antigen |
JP2000508922A (en) | 1996-04-26 | 2000-07-18 | ケース ウエスターン リザーブ ユニバーシティ | Skin regeneration using mesenchymal stem cells |
US5919176A (en) | 1996-05-14 | 1999-07-06 | Children's Hospital Medical Center Of Northern California | Apparatus and method for collecting blood from an umbilical cord |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US6358737B1 (en) | 1996-07-31 | 2002-03-19 | Board Of Regents, The University Of Texas System | Osteocyte cell lines |
US5851984A (en) | 1996-08-16 | 1998-12-22 | Genentech, Inc. | Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides |
US5916202A (en) * | 1996-08-30 | 1999-06-29 | Haswell; John N. | Umbilical cord blood collection |
US6227202B1 (en) | 1996-09-03 | 2001-05-08 | Maulana Azad Medical College | Method of organogenesis and tissue regeneration/repair using surgical techniques |
US5945337A (en) | 1996-10-18 | 1999-08-31 | Quality Biological, Inc. | Method for culturing CD34+ cells in a serum-free medium |
US5919702A (en) | 1996-10-23 | 1999-07-06 | Advanced Tissue Science, Inc. | Production of cartilage tissue using cells isolated from Wharton's jelly |
US5969105A (en) | 1996-10-25 | 1999-10-19 | Feng; Yiqing | Stem cell factor receptor agonists |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US6152142A (en) | 1997-02-28 | 2000-11-28 | Tseng; Scheffer C. G. | Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries |
US6231880B1 (en) | 1997-05-30 | 2001-05-15 | Susan P. Perrine | Compositions and administration of compositions for the treatment of blood disorders |
ES2285779T3 (en) | 1997-07-03 | 2007-11-16 | Osiris Therapeutics, Inc. | MESENQUIMATOSAS HUMAN MOTHER CELLS OF PERIPHERAL BLOOD. |
ATE307195T1 (en) | 1997-07-14 | 2005-11-15 | Osiris Therapeutics Inc | CARDIAC MUSCLE REGENERATION USING MESENCHYMAL STEM CELLS |
US7514074B2 (en) | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
US6077708A (en) | 1997-07-18 | 2000-06-20 | Collins; Paul C. | Method of determining progenitor cell content of a hematopoietic cell culture |
US5879318A (en) * | 1997-08-18 | 1999-03-09 | Npbi International B.V. | Method of and closed system for collecting and processing umbilical cord blood |
WO1999011287A1 (en) * | 1997-09-04 | 1999-03-11 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
US6093531A (en) | 1997-09-29 | 2000-07-25 | Neurospheres Holdings Ltd. | Generation of hematopoietic cells from multipotent neural stem cells |
US6800480B1 (en) | 1997-10-23 | 2004-10-05 | Geron Corporation | Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture |
US6248587B1 (en) | 1997-11-26 | 2001-06-19 | University Of Southern Cailfornia | Method for promoting mesenchymal stem and lineage-specific cell proliferation |
US6059968A (en) | 1998-01-20 | 2000-05-09 | Baxter International Inc. | Systems for processing and storing placenta/umbilical cord blood |
US6291240B1 (en) | 1998-01-29 | 2001-09-18 | Advanced Tissue Sciences, Inc. | Cells or tissues with increased protein factors and methods of making and using same |
WO1999046366A1 (en) * | 1998-03-13 | 1999-09-16 | Osiris Therapeutics, Inc. | Uses for humane non-autologous mesenchymal stem cells |
JP4740452B2 (en) | 1998-03-18 | 2011-08-03 | オシリス セラピューティクス,インコーポレイテッド | Methods, compositions and methods of using mesenchymal stem cells for the prevention and treatment of immune responses in transplantation |
US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
DK1066060T3 (en) | 1998-04-03 | 2003-11-24 | Osiris Therapeutics Inc | Mesenchymal stem cells as immunosuppressive agents |
WO1999056753A1 (en) | 1998-05-04 | 1999-11-11 | Point Therapeutics, Inc. | Hematopoietic stimulation |
AU3888699A (en) | 1998-05-07 | 1999-11-23 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
US6835377B2 (en) | 1998-05-13 | 2004-12-28 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration |
CA2328425A1 (en) | 1998-05-22 | 1999-12-02 | Osiris Therapeutics, Inc. | Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells |
ATE368731T1 (en) | 1998-05-29 | 2007-08-15 | Osiris Therapeutics Inc | HUMAN CD45+ AND/OR FIBROBLASTS+ MESENCHYMAL STEM CELLS |
JP4526186B2 (en) * | 1998-06-08 | 2010-08-18 | オシリス セラピューティクス,インコーポレイテッド | Methods and compositions for maintaining hematopoietic stem cells in vitro |
CA2330190C (en) | 1998-06-08 | 2009-12-22 | Osiris Therapeutics, Inc. | Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
US6713245B2 (en) | 1998-07-06 | 2004-03-30 | Diacrin, Inc. | Methods for storing neural cells such that they are suitable for transplantation |
JP4778143B2 (en) * | 1998-07-28 | 2011-09-21 | アルツケム トロストベルク ゲゼルシャフト ミット ベシュレンクテル ハフツング | Use of creatine compounds for the treatment of bone or chondrocytes and tissues |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
JP3517359B2 (en) | 1998-09-14 | 2004-04-12 | テルモ株式会社 | Cell separation / collection apparatus and cell separation / collection method |
WO2000017325A1 (en) | 1998-09-23 | 2000-03-30 | Mount Sinai Hospital | Trophoblast cell preparations |
JP2002529070A (en) * | 1998-11-09 | 2002-09-10 | モナシュ・ユニヴァーシティ | Embryonic stem cells |
US6548299B1 (en) * | 1999-11-12 | 2003-04-15 | Mark J. Pykett | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
CN1180079C (en) | 1998-11-12 | 2004-12-15 | 基质细胞有限责任公司 | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US6102871A (en) | 1998-11-23 | 2000-08-15 | Coe; Rosemarie O. | Blood collection funnel |
US6328765B1 (en) | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
PT1144026E (en) | 1998-12-24 | 2004-12-31 | Biosafe Sa | SYSTEM FOR BLOOD SEPARATION USEFUL, IN PARTICULAR, FOR CONCENTRATIONS OF HEMATOPOIETIC STEM CELLS |
EP2208782B1 (en) | 1999-02-04 | 2017-05-31 | Pluristem Ltd. | Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
DE60026983T2 (en) | 1999-04-16 | 2007-01-25 | William Marsh Rice University, Houston | FUNCTIONALIZED POLYPROPYLENE FUMARATE AND POLYPROPYLENE FUMARATE COETHYLENE GLYCOL |
IN191359B (en) | 1999-04-20 | 2003-11-29 | Nat Inst Immunology | |
AU4860900A (en) | 1999-06-02 | 2000-12-18 | Lifebank Services, L.L.C. | Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells |
US6333029B1 (en) | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
US7838289B2 (en) | 2001-02-14 | 2010-11-23 | Abt Holding Company | Assay utilizing multipotent adult stem cells |
US7015037B1 (en) | 1999-08-05 | 2006-03-21 | Regents Of The University Of Minnesota | Multiponent adult stem cells and methods for isolation |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
IL147990A0 (en) | 1999-08-05 | 2002-09-12 | Mcl Llc | Multipotent adult stem cells and methods for isolation |
US8147824B2 (en) | 1999-08-05 | 2012-04-03 | Athersys, Inc. | Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
US6239157B1 (en) | 1999-09-10 | 2001-05-29 | Osiris Therapeutics, Inc. | Inhibition of osteoclastogenesis |
WO2001021767A2 (en) | 1999-09-24 | 2001-03-29 | Morphogen Pharmaceuticals, Inc. | Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US6280718B1 (en) | 1999-11-08 | 2001-08-28 | Wisconsin Alumni Reasearch Foundation | Hematopoietic differentiation of human pluripotent embryonic stem cells |
DE19954421A1 (en) | 1999-11-12 | 2001-05-31 | Lohmann Therapie Syst Lts | Film-like preparation for the biphase release of pharmacologically active or other substances |
JP2003530826A (en) | 1999-11-17 | 2003-10-21 | ユニバーシティー オブ ロチェスター | Human ex vivo immune system |
US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
EP1263930A4 (en) | 2000-03-09 | 2004-07-21 | Saneron Ccel Therapeutics Inc | Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
EP1264877B1 (en) | 2000-03-16 | 2013-10-02 | Cellseed Inc. | Cell cultivation-support material, method of cocultivation of cells and cocultivated cell sheet obtained therefrom |
US20010038836A1 (en) | 2000-04-04 | 2001-11-08 | Matthew During | Application of myeloid-origin cells to the nervous system |
ATE332708T1 (en) | 2000-06-06 | 2006-08-15 | Glaxo Group Ltd | CANCER TREATMENT COMPOSITION CONTAINING AN ANTINEOPLASTIC AGENT AND PDE4 INHIBITOR |
US20050009876A1 (en) * | 2000-07-31 | 2005-01-13 | Bhagwat Shripad S. | Indazole compounds, compositions thereof and methods of treatment therewith |
US7560280B2 (en) | 2000-11-03 | 2009-07-14 | Kourion Therapeutics Gmbh | Human cord blood derived unrestricted somatic stem cells (USSC) |
IL155728A0 (en) | 2000-11-22 | 2003-11-23 | Geron Corp | Tolerizing allografts of pluripotent stem cells |
AU2002220209B2 (en) | 2000-12-06 | 2006-05-25 | Robert J. Hariri | Method of collecting placental stem cells |
US20030032179A1 (en) * | 2000-12-06 | 2003-02-13 | Hariri Robert J. | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
US20080152629A1 (en) | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
US7091353B2 (en) | 2000-12-27 | 2006-08-15 | Celgene Corporation | Isoindole-imide compounds, compositions, and uses thereof |
US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
KR101012952B1 (en) * | 2001-02-14 | 2011-02-08 | 안트로제네시스 코포레이션 | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US20020132343A1 (en) | 2001-03-19 | 2002-09-19 | Clark Lum | System and method for delivering umbilical cord-derived tissue-matched stem cells for transplantation |
US20030044977A1 (en) | 2001-08-10 | 2003-03-06 | Norio Sakuragawa | Human stem cells originated from human amniotic mesenchymal cell layer |
DE10139783C1 (en) | 2001-08-14 | 2003-04-17 | Transtissue Technologies Gmbh | Cell compositions for the treatment of osteoarthritis, and methods for their production |
US20030044976A1 (en) | 2001-08-27 | 2003-03-06 | Advanced Cell Technology | De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
EP1288293A1 (en) | 2001-08-30 | 2003-03-05 | Norio Sakuragawa | Human neural stem cells originated from human amniotic mesenchymal cell layer |
US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
KR20050044395A (en) | 2001-11-09 | 2005-05-12 | 아르테셀 사이언스, 인크. | Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
AU2002363659B2 (en) | 2001-11-15 | 2008-09-25 | Children's Medical Center Corporation | Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof |
JP3728750B2 (en) | 2001-11-22 | 2005-12-21 | ニプロ株式会社 | Cultured skin and method for producing the same |
US7799324B2 (en) | 2001-12-07 | 2010-09-21 | Geron Corporation | Using undifferentiated embryonic stem cells to control the immune system |
JP3934539B2 (en) | 2001-12-12 | 2007-06-20 | 独立行政法人科学技術振興機構 | Adult or postnatal tissue progenitor cells derived from placenta |
WO2003055989A2 (en) * | 2001-12-21 | 2003-07-10 | Mount Sinai Hospital | Cellular compositions and methods of making and using them |
US20040018178A1 (en) * | 2002-01-22 | 2004-01-29 | Advanced Cell Technology | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
JP2005517402A (en) * | 2002-02-13 | 2005-06-16 | アンスロジェネシス コーポレーション | Embryo-like stem cells derived from the post-partum mammalian placenta, uses of the cells and therapeutic methods using the cells |
EP1483371B1 (en) * | 2002-02-19 | 2007-06-27 | Medipost, Co., Ltd. | Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood, and differentiation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into various mesenchymal tissues |
US7736892B2 (en) | 2002-02-25 | 2010-06-15 | Kansas State University Research Foundation | Cultures, products and methods using umbilical cord matrix cells |
US20030161818A1 (en) | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
US20080299090A1 (en) | 2002-02-25 | 2008-12-04 | Kansas State University Research Foundation | Use Of Umbilical Cord Matrix Cells |
WO2003077865A2 (en) | 2002-03-15 | 2003-09-25 | Baxter International Inc. | Methods and compositions for directing cells to target organs |
US20030187515A1 (en) | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
AU2003221173A1 (en) * | 2002-03-27 | 2003-10-08 | Asahi Kasei Kabushiki Kaisha | Placenta-origin mesenchymal cells and medicinal use thereof |
MXPA04009997A (en) * | 2002-04-12 | 2004-12-13 | Celgene Corp | Modulation of stem and progenitor cell differentiation, assays, and uses thereof. |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
KR20050000398A (en) | 2002-04-12 | 2005-01-03 | 셀진 코포레이션 | Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
US20040161419A1 (en) | 2002-04-19 | 2004-08-19 | Strom Stephen C. | Placental stem cells and uses thereof |
EP1497435A4 (en) | 2002-04-19 | 2005-07-27 | Univ Pittsburgh | Placental derived stem cells and uses thereof |
US20050058641A1 (en) | 2002-05-22 | 2005-03-17 | Siemionow Maria Z. | Tolerance induction and maintenance in hematopoietic stem cell allografts |
JP2005528105A (en) * | 2002-05-30 | 2005-09-22 | セルジーン・コーポレーション | Methods of using JNK or MKK inhibitors to modulate cell differentiation and to treat myeloproliferative diseases and myelodysplastic syndromes |
US20040033217A1 (en) | 2002-05-31 | 2004-02-19 | Padmavathy Vanguri | Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
AU2003278212B2 (en) | 2002-07-31 | 2009-07-09 | Centre National De La Recherche Scientifique | Stem cells derived from adipous tissue and differentiated cells derived from said cells |
WO2004018658A1 (en) | 2002-08-23 | 2004-03-04 | Srl, Inc. | Human bone stem cells |
KR100476790B1 (en) | 2002-09-13 | 2005-03-16 | 주식회사 제넨메드 | A cell preservation solution and the freezing and preservation procedures of animal cells using the said solution |
US20040062753A1 (en) | 2002-09-27 | 2004-04-01 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
KR101042448B1 (en) | 2002-11-26 | 2011-06-16 | 안트로제네시스 코포레이션 | Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
JP2004210713A (en) * | 2002-12-27 | 2004-07-29 | Asahi Kasei Corp | Medical cell preparation derived from placenta |
JP4790592B2 (en) | 2003-02-11 | 2011-10-12 | ダビース,ジヨン・イー | Progenitor cells from Wharton's jelly of human umbilical cord |
NZ566132A (en) | 2003-02-13 | 2009-09-25 | Anthrogenesis Corp | Use of umbilical cord blood to treat inflammation, ParkinsonÆs disease or diabetes |
WO2004087896A2 (en) | 2003-03-31 | 2004-10-14 | Pfizer Products Inc. | Hepatocyte differentiation of stem cells |
CN1548529A (en) | 2003-05-09 | 2004-11-24 | 中国人民解放军军事医学科学院基础医 | Separation method of buffering stem cell in human placenta |
EP1641913B1 (en) | 2003-06-27 | 2016-01-06 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US7875272B2 (en) | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
US20050042595A1 (en) * | 2003-08-14 | 2005-02-24 | Martin Haas | Banking of multipotent amniotic fetal stem cells |
AR046123A1 (en) | 2003-10-17 | 2005-11-23 | Crc For Innovative Dairy Produ | SIMULATION OF MOTHER SIMIL CELLS, USE OF THE SAME |
US20050089513A1 (en) * | 2003-10-28 | 2005-04-28 | Norio Sakuragawa | Side population cells originated from human amnion and their uses |
EP1682654A2 (en) | 2003-11-10 | 2006-07-26 | Amgen Inc. | Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
KR100560340B1 (en) * | 2003-11-11 | 2006-03-14 | 한훈 | Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood |
JP2005151907A (en) | 2003-11-27 | 2005-06-16 | Shigeo Saito | Human stem cell derived from placenta or amnion and method for establishing the same and method for differentiation-induction to organ |
TWI338714B (en) | 2003-12-02 | 2011-03-11 | Cathay General Hospital | Method of isolation and enrichment of mesenchymal stem cells from amniotic fluid |
WO2005055929A2 (en) | 2003-12-02 | 2005-06-23 | Celgene Corporation | Methods and compositions for the treatment and management of hemoglobinopathy and anemia |
US8586357B2 (en) * | 2003-12-23 | 2013-11-19 | Viacyte, Inc. | Markers of definitive endoderm |
US20050176139A1 (en) | 2004-01-12 | 2005-08-11 | Yao-Chang Chen | Placental stem cell and methods thereof |
US20050266391A1 (en) | 2004-01-15 | 2005-12-01 | Bennett Brydon L | Methods for preserving tissue |
JP2007530543A (en) | 2004-03-22 | 2007-11-01 | オシリス セラピューティクス,インコーポレイテッド | Mesenchymal stem cells and use thereof |
US20080095749A1 (en) | 2004-03-22 | 2008-04-24 | Sudeepta Aggarwal | Mesenchymal stem cells and uses therefor |
ZA200607800B (en) | 2004-03-26 | 2009-02-25 | Celgene Corp | System and methods for providing a stem cell bank |
WO2005105992A1 (en) | 2004-04-21 | 2005-11-10 | New York Eye & Ear Infirmary | Chondrocyte culture formulations |
JP2006006249A (en) | 2004-06-28 | 2006-01-12 | Hiroshima Univ | Method for culturing amnion-derived cell and utilization of the same |
CN100564518C (en) | 2004-07-20 | 2009-12-02 | 成都军区昆明总医院 | Placenta amnion cell extract and induce application in the differentiation at mescenchymal stem cell |
US7244759B2 (en) | 2004-07-28 | 2007-07-17 | Celgene Corporation | Isoindoline compounds and methods of making and using the same |
US20080292597A1 (en) | 2004-07-29 | 2008-11-27 | David A Steenblock | Umbilical Cord Stem Cell Composition & Method of Treating Neurological Diseases |
KR101322889B1 (en) * | 2004-08-16 | 2013-10-30 | 셀리서치 코포레이션 피티이 리미티드 | Isolation of stem/progenitor cells from amniotic membrane of umbilical cord |
US20090104158A1 (en) | 2004-09-03 | 2009-04-23 | Moraga Biotechnology Corporation | Non-Embryonic Totipotent Blastomere-Like Stem Cells And Methods Therefor |
WO2006030442A2 (en) | 2004-09-16 | 2006-03-23 | Gamida-Cell Ltd. | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
US7909806B2 (en) | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
US7147626B2 (en) * | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
WO2006032092A1 (en) | 2004-09-24 | 2006-03-30 | Angioblast Systems, Inc. | Multipotential expanded mesenchymal precursor cell progeny (memp) and uses thereof |
US20060069009A1 (en) | 2004-09-28 | 2006-03-30 | Messina Darin J | Treatment of neurological deficits in the striatum or substanta nigra pars compacta |
US8039258B2 (en) | 2004-09-28 | 2011-10-18 | Ethicon, Inc. | Tissue-engineering scaffolds containing self-assembled-peptide hydrogels |
US20060069008A1 (en) | 2004-09-28 | 2006-03-30 | Sanjay Mistry | Treatment of neurological deficits in the striatum or substanta nigra pars compacta |
WO2006083394A2 (en) | 2004-12-21 | 2006-08-10 | Ethicon, Inc. | Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same |
WO2006101548A2 (en) | 2004-12-21 | 2006-09-28 | Ethicon, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same |
PL1831356T3 (en) | 2004-12-23 | 2017-07-31 | DePuy Synthes Products, Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
CA2592435C (en) | 2004-12-23 | 2017-03-28 | Ethicon, Incorporated | Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells |
US20070041943A1 (en) | 2004-12-29 | 2007-02-22 | Children's Hospital Research | Expression of virus entry inhibitors and recombinant AAV thereof |
EP1833494B1 (en) * | 2005-01-07 | 2016-05-18 | Wake Forest University Health Sciences | Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
US7642091B2 (en) * | 2005-02-24 | 2010-01-05 | Jau-Nan Lee | Human trophoblast stem cells and use thereof |
US20060222634A1 (en) | 2005-03-31 | 2006-10-05 | Clarke Diana L | Amnion-derived cell compositions, methods of making and uses thereof |
US20100028306A1 (en) | 2005-03-31 | 2010-02-04 | Stemnion, Inc. | Amnion-Derived Cell Compositions, Methods of Making and Uses Thereof |
KR101446634B1 (en) | 2005-04-12 | 2014-10-16 | 메소블라스트, 아이엔씨. | Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase |
WO2006117889A1 (en) | 2005-04-28 | 2006-11-09 | Stemcell Institute Inc. | Method of preparing organ for transplantation |
EP2210937A1 (en) | 2005-05-09 | 2010-07-28 | Olympus Corporation | Culture method for mesenchymal stem cell and process for production of supporting material for biological tissue |
AU2006202209B2 (en) | 2005-05-27 | 2011-04-14 | Lifescan, Inc. | Amniotic fluid derived cells |
ZA200800144B (en) * | 2005-06-10 | 2010-02-24 | Celgene Corp | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
EP1901789A2 (en) * | 2005-06-30 | 2008-03-26 | Anthrogenesis Corporation | Repair of tympanic membrane using placenta derived collagen biofabric |
WO2007009062A2 (en) * | 2005-07-13 | 2007-01-18 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
EP1919365A2 (en) * | 2005-07-13 | 2008-05-14 | Anthrogenesis Corporation | Ocular plug formed from placenta derived collagen biofabric |
WO2007011693A2 (en) * | 2005-07-14 | 2007-01-25 | Medistem Laboratories, Inc. | Compositions of placentally-derived stem cells for the treatment of cancer |
US7923007B2 (en) | 2005-08-08 | 2011-04-12 | Academia Sinica | Brain tissue damage therapies |
US20080226612A1 (en) | 2005-08-19 | 2008-09-18 | Bio Regenerate, Inc. | Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof |
ZA200803929B (en) | 2005-10-13 | 2009-08-26 | Anthrogenesis Corp | Production of oligodendrocytes from placenta-derived stem cells |
ZA200803930B (en) * | 2005-10-13 | 2010-03-31 | Anthrogenesis Corp | Immunomodulation using placental stem cells |
PL1971681T3 (en) | 2005-12-16 | 2018-01-31 | Depuy Synthes Products Inc | Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
WO2007073552A1 (en) | 2005-12-19 | 2007-06-28 | Ethicon, Inc. | In vitro expansion of postpartum derived cells in roller bottles |
SG10201401805YA (en) | 2005-12-22 | 2014-08-28 | Jane Ennis | Viable cells from frozen umbilical cord tissue |
WO2007076522A2 (en) | 2005-12-28 | 2007-07-05 | Ethicon, Incorporated | Treatment of peripheral vascular disease using postpartum-derived cells |
KR20210122908A (en) | 2005-12-29 | 2021-10-12 | 안트로제네시스 코포레이션 | Placental stem cell populations |
AU2006332679A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
AU2006332680A1 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
US20080286249A1 (en) | 2006-01-12 | 2008-11-20 | Varney Timothy R | Use of mesenchymal stem cells for treating genetic diseases and disorders |
US20070253931A1 (en) | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
CA2893204C (en) | 2006-01-13 | 2016-11-29 | Alla Danilkovitch | Mesenchymal stem cells expressing tnf-.alpha. receptors |
CN100545260C (en) | 2006-01-13 | 2009-09-30 | 深圳市北科生物科技有限公司 | The separation of human amnion mesenchymal stem cell and cultural method and medical composition |
US9944900B2 (en) | 2006-01-18 | 2018-04-17 | Hemacell Perfusion | Pulsatile perfusion extraction method for non-embryonic pluripotent stem cells |
JP5432527B2 (en) | 2006-01-23 | 2014-03-05 | アサーシス,インコーポレーテッド | MAPC treatment of brain injury and disease |
CA3124132A1 (en) | 2006-01-23 | 2007-08-02 | Abt Holding Company | Mapc therapeutics without adjunctive immunosuppressive treatment |
EP1845154A1 (en) | 2006-04-12 | 2007-10-17 | RNL Bio Co., Ltd. | Multipotent stem cells derived from placenta tissue and cellular therapeutic agents comprising the same |
CN101483998A (en) | 2006-05-11 | 2009-07-15 | 武部直子 | Methods for collecting and using placenta cord blood stem cells |
WO2007136673A2 (en) | 2006-05-19 | 2007-11-29 | Medistem Laboratories, Inc. | Treatment of disc degenerative disease and compositions for same |
WO2007146105A2 (en) | 2006-06-05 | 2007-12-21 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
US20080050814A1 (en) | 2006-06-05 | 2008-02-28 | Cryo-Cell International, Inc. | Procurement, isolation and cryopreservation of fetal placental cells |
CN101501185A (en) * | 2006-06-09 | 2009-08-05 | 人类起源公司 | Placental niche and use thereof to culture stem cells |
US20070287176A1 (en) | 2006-06-13 | 2007-12-13 | Alireza Rezania | Chorionic villus derived cells |
US8475788B2 (en) | 2006-06-14 | 2013-07-02 | Stemnion, Inc. | Methods of treating spinal cord injury and minimizing scarring |
WO2007149548A2 (en) | 2006-06-22 | 2007-12-27 | Medistem Laboratories, Inc. | Treatment of erectile dysfunction by stem cell therapy |
EP2046946B8 (en) | 2006-06-26 | 2017-01-25 | Lifescan, Inc. | Pluripotent stem cell culture |
WO2008003042A2 (en) | 2006-06-28 | 2008-01-03 | The University Of Medicine And Dentistry Of New Jersey | Amnion-derived stem cells and uses thereof |
US7993918B2 (en) | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
US20090081171A1 (en) | 2006-08-11 | 2009-03-26 | Yu-Show Fu | Cell system for alleviating syndromes of Parkinson's disease in a mammal |
US8105634B2 (en) * | 2006-08-15 | 2012-01-31 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
US20080050347A1 (en) | 2006-08-23 | 2008-02-28 | Ichim Thomas E | Stem cell therapy for cardiac valvular dysfunction |
WO2008036374A2 (en) | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
US20080131522A1 (en) | 2006-10-03 | 2008-06-05 | Qing Liu | Use of placental biomaterial for ocular surgery |
US8071135B2 (en) | 2006-10-04 | 2011-12-06 | Anthrogenesis Corporation | Placental tissue compositions |
CN101622007A (en) | 2006-10-06 | 2010-01-06 | 人类起源公司 | Natural (end peptide) placental collagen compositions |
DK2084268T3 (en) | 2006-10-23 | 2019-01-21 | Celularity Inc | METHODS AND COMPOSITIONS FOR TREATING BONE JOIN DEFECTS WITH PLACENTACLE POPULATIONS |
ES2524443T3 (en) | 2006-11-13 | 2014-12-09 | DePuy Synthes Products, LLC | In vitro expansion of postpartum cells using microcarriers |
US8241621B2 (en) | 2006-12-18 | 2012-08-14 | Medistem Laboratories | Stem cell mediated treg activation/expansion for therapeutic immune modulation |
DK2120977T3 (en) | 2007-02-12 | 2013-08-12 | Anthrogenesis Corp | Treatment of inflammatory diseases using placental stem cells |
EP2129775A1 (en) | 2007-02-12 | 2009-12-09 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
US20100172830A1 (en) | 2007-03-29 | 2010-07-08 | Cellx Inc. | Extraembryonic Tissue cells and method of use thereof |
US20080254005A1 (en) | 2007-04-06 | 2008-10-16 | Medistem Labortories | Stem Cell Therapy for the Treatment of Autism and Other Disorders |
KR101644659B1 (en) * | 2007-09-26 | 2016-08-01 | 안트로제네시스 코포레이션 | Angiogenic cells from human placental perfusate |
KR20210022148A (en) | 2007-09-28 | 2021-03-02 | 안트로제네시스 코포레이션 | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
KR20160040739A (en) | 2007-11-07 | 2016-04-14 | 안트로제네시스 코포레이션 | Use of umbilical cord blood in the treatment of premature birth complications |
US8216997B2 (en) | 2008-08-14 | 2012-07-10 | Acceleron Pharma, Inc. | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
KR101903049B1 (en) * | 2008-08-20 | 2018-11-07 | 안트로제네시스 코포레이션 | Treatment of stroke using isolated placental cells |
KR20110050521A (en) * | 2008-08-20 | 2011-05-13 | 안트로제네시스 코포레이션 | Improved cell composition and methods of making the same |
KR20110050688A (en) * | 2008-08-22 | 2011-05-16 | 안트로제네시스 코포레이션 | Methods and compositions for treatment of bone defects with placental cell populations |
AU2009316541B2 (en) | 2008-11-19 | 2015-08-06 | Celularity Inc. | Amnion derived adherent cells |
ES2731340T3 (en) | 2008-11-21 | 2019-11-15 | Celularity Inc | Treatment of diseases, disorders or lung conditions using placental cells |
US20100323446A1 (en) | 2009-06-05 | 2010-12-23 | Jill Renee Barnett | Method of collecting placental cells |
CA2767014C (en) * | 2009-07-02 | 2022-01-25 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
EP3284818B1 (en) | 2010-01-26 | 2022-03-09 | Celularity Inc. | Treatment of bone-related cancers using placental stem cells |
US20110280849A1 (en) | 2010-03-26 | 2011-11-17 | Anthrogenesis Corporation | Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compounds |
KR20230054905A (en) | 2010-04-07 | 2023-04-25 | 셀룰래리티 인코포레이티드 | Angiogenesis using placental stem cells |
WO2011127113A1 (en) | 2010-04-08 | 2011-10-13 | Anthrogenesis Corporation | Treatment of sarcoidosis using placental stem cells |
ES2666746T3 (en) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Methods to generate natural cytolytic lymphocytes |
KR20230084328A (en) | 2010-12-30 | 2023-06-12 | 셀룰래리티 인코포레이티드 | Methods for cryopreserving and encapsulating cells |
US20120171180A1 (en) | 2010-12-30 | 2012-07-05 | Sascha Abramson | Compositions comprising amnion derived adherent cells and platelet-rich plasma |
AR084754A1 (en) | 2010-12-30 | 2013-06-05 | Anthrogenesis Corp | COMPOSITIONS THAT INCLUDE MOTHER PLACENTA CELLS AND PLASMA RICH IN PLATES, AND THEIR METHODS OF USE |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
PL2714059T3 (en) | 2011-06-01 | 2019-04-30 | Celularity Inc | Treatment of pain using placental stem cells |
-
2006
- 2006-12-28 KR KR1020217031368A patent/KR20210122908A/en not_active Application Discontinuation
- 2006-12-28 CN CN201310405648.2A patent/CN103525758B/en active Active
- 2006-12-28 PL PL12150928T patent/PL2471906T3/en unknown
- 2006-12-28 US US11/648,813 patent/US8057788B2/en not_active Expired - Lifetime
- 2006-12-28 PT PT12150934T patent/PT2471907T/en unknown
- 2006-12-28 PT PT12150919T patent/PT2471904T/en unknown
- 2006-12-28 EP EP18196002.2A patent/EP3486314B1/en active Active
- 2006-12-28 PL PL12150919T patent/PL2471904T3/en unknown
- 2006-12-28 DK DK12150928.5T patent/DK2471906T3/en active
- 2006-12-28 KR KR1020227015349A patent/KR20220063304A/en not_active Application Discontinuation
- 2006-12-28 KR KR1020187026653A patent/KR20180105266A/en not_active Application Discontinuation
- 2006-12-28 KR KR1020197025129A patent/KR20190104428A/en active Application Filing
- 2006-12-28 PT PT12150928T patent/PT2471906T/en unknown
- 2006-12-28 NZ NZ622377A patent/NZ622377A/en unknown
- 2006-12-28 KR KR1020087018508A patent/KR101585241B1/en active IP Right Grant
- 2006-12-28 ES ES12150924T patent/ES2703502T3/en active Active
- 2006-12-28 ES ES12150934T patent/ES2706726T3/en active Active
- 2006-12-28 PL PL06848281T patent/PL1976977T3/en unknown
- 2006-12-28 ES ES12150928T patent/ES2708933T3/en active Active
- 2006-12-28 NZ NZ595786A patent/NZ595786A/en unknown
- 2006-12-28 NZ NZ569562A patent/NZ569562A/en unknown
- 2006-12-28 CN CN200680053575.3A patent/CN101395266B/en active Active
- 2006-12-28 DK DK12150934.3T patent/DK2471907T3/en active
- 2006-12-28 KR KR1020207030297A patent/KR20200123283A/en not_active Application Discontinuation
- 2006-12-28 CN CN201810489408.8A patent/CN108559725A/en active Pending
- 2006-12-28 ES ES12150912.9T patent/ES2671355T3/en active Active
- 2006-12-28 EP EP12150928.5A patent/EP2471906B1/en active Active
- 2006-12-28 EP EP12150924.4A patent/EP2471905B1/en active Active
- 2006-12-28 CN CN201210477851.6A patent/CN103060263B/en active Active
- 2006-12-28 ES ES06848281.9T patent/ES2549111T3/en active Active
- 2006-12-28 WO PCT/US2006/049491 patent/WO2007079183A2/en active Application Filing
- 2006-12-28 PL PL12150924T patent/PL2471905T3/en unknown
- 2006-12-28 DK DK12150912.9T patent/DK2471903T3/en active
- 2006-12-28 NZ NZ712789A patent/NZ712789A/en unknown
- 2006-12-28 US US11/648,804 patent/US20080032401A1/en not_active Abandoned
- 2006-12-28 KR KR1020237019606A patent/KR20230091193A/en not_active Application Discontinuation
- 2006-12-28 DK DK12150924.4T patent/DK2471905T3/en active
- 2006-12-28 CN CN201310024293.2A patent/CN103146640B/en active Active
- 2006-12-28 JP JP2008548745A patent/JP5550235B2/en active Active
- 2006-12-28 EP EP12150919.4A patent/EP2471904B1/en active Active
- 2006-12-28 AU AU2006332678A patent/AU2006332678B2/en active Active
- 2006-12-28 PL PL12150912T patent/PL2471903T3/en unknown
- 2006-12-28 EP EP12150912.9A patent/EP2471903B1/en active Active
- 2006-12-28 ES ES12150919T patent/ES2711278T3/en active Active
- 2006-12-28 KR KR1020177008335A patent/KR101900809B1/en active IP Right Grant
- 2006-12-28 PL PL12150934T patent/PL2471907T3/en unknown
- 2006-12-28 CA CA2635253A patent/CA2635253C/en active Active
- 2006-12-28 CA CA2957336A patent/CA2957336C/en active Active
- 2006-12-28 PT PT121509129T patent/PT2471903T/en unknown
- 2006-12-28 DK DK12150919.4T patent/DK2471904T3/en active
- 2006-12-28 KR KR1020157020367A patent/KR101722577B1/en active IP Right Grant
- 2006-12-28 PT PT12150924T patent/PT2471905T/en unknown
- 2006-12-28 EP EP12150934.3A patent/EP2471907B1/en active Active
- 2006-12-28 EP EP06848281.9A patent/EP1976977B1/en active Active
- 2006-12-29 PE PE2006001722A patent/PE20080146A1/en not_active Application Discontinuation
-
2008
- 2008-06-25 MX MX2018012512A patent/MX2018012512A/en unknown
- 2008-06-25 MX MX2013009297A patent/MX338534B/en unknown
- 2008-06-25 MX MX2014002006A patent/MX348414B/en unknown
- 2008-06-25 MX MX2020001944A patent/MX2020001944A/en unknown
- 2008-06-26 IL IL192457A patent/IL192457A0/en active IP Right Grant
-
2010
- 2010-06-11 ZA ZA2010/04182A patent/ZA201004182B/en unknown
- 2010-07-30 US US12/848,007 patent/US8202703B2/en active Active
-
2012
- 2012-05-16 US US13/473,509 patent/US8591883B2/en active Active
- 2012-05-24 US US13/480,370 patent/US8691217B2/en active Active
- 2012-11-20 IL IL223156A patent/IL223156A0/en active IP Right Grant
- 2012-11-20 IL IL243876A patent/IL243876B/en active IP Right Grant
- 2012-11-22 IL IL223194A patent/IL223194A/en active IP Right Grant
-
2013
- 2013-01-10 JP JP2013002575A patent/JP5739918B2/en active Active
- 2013-10-29 HK HK13112141.8A patent/HK1184817A1/en unknown
-
2014
- 2014-02-14 US US14/181,159 patent/US9078898B2/en active Active
-
2015
- 2015-06-10 US US14/735,727 patent/US10383897B2/en active Active
-
2016
- 2016-01-31 IL IL243876A patent/IL243876A0/en unknown
-
2017
- 2017-05-08 ZA ZA2017/03181A patent/ZA201703181B/en unknown
-
2019
- 2019-05-28 IL IL266958A patent/IL266958A/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1407088A (en) * | 2001-09-06 | 2003-04-02 | 周胜利 | Method for establishing hematopoietic stem cells bank by extracting hematopoietic cells from placenta tissues |
WO2006111706A1 (en) * | 2005-04-16 | 2006-10-26 | Axordia Limited | Cytotrophoblast stem cell |
WO2007047468A2 (en) * | 2005-10-13 | 2007-04-26 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
CN1786154A (en) * | 2005-10-18 | 2006-06-14 | 天津昂赛细胞基因工程有限公司 | Human placenta, umbilical cord mesenchyma stemcell stock and its construction method |
Non-Patent Citations (12)
Title |
---|
ANKER IN'T P ET AL: "Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta", STEM CELLS, ALPHAMED PRESS, DAYTON, OH, US, vol. 22, no. 7, 2004, pages 1338 - 1345, XP002371702, ISSN: 1066-5099 * |
CLARK DAVID A ET AL: "Placental trophoblast from successful human pregnancies expresses the tolerance signaling molecule, CD200 (OX-2)", AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, vol. 50, no. 3, September 2003 (2003-09-01), pages 187 - 195, XP002430047, ISSN: 1046-7408 * |
DATABASE WPI Week 200357, Derwent World Patents Index; AN 2003-599015, XP002443363 * |
DATABASE WPI Week 200676, Derwent World Patents Index; AN 2006-730789, XP002443364 * |
FRANK H G ET AL: "Cell culture models of human trophoblast: primary culture of trophoblast--a workshop report.", PLACENTA APR 2001, vol. 22 Suppl A, April 2001 (2001-04-01), pages S107 - S109, XP002443188, ISSN: 0143-4004 * |
HARBACHEUSKI RYHOR ET AL: "Placenta derived adherent cells (PDACs) suppress tumor cells of diverse origin.", BLOOD, vol. 108, no. 11, Part 2, November 2006 (2006-11-01), & SYMPOSIUM OF THE INTERNATIONAL-SOCIETY-OF-MOLECULAR-EVOLUTION; GUANANACASTE, COSTA RICA; JANUARY 08 -12, 2001, pages 288B, XP009084838, ISSN: 0006-4971 * |
HOEK R M ET AL: "Down-regulation of the macrophage lineage through interaction with OX2 (CD200)", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 290, no. 5497, 1 December 2000 (2000-12-01), pages 1768 - 1771, XP002263649, ISSN: 0036-8075 * |
LI CHANG DONG ET AL: "MESENCHYMAL STEM CELLS DERIVED FROM HUMAN PLACENTA SUPPRESS ALLOGENEIC UMBILICAL CORD BLOOD LYMPHOCYTE PROLIFERATION", CELL RESEARCH - XIBAO YANJIU, BEIJING, CN, vol. 15, no. 7, July 2005 (2005-07-01), pages 539 - 547, XP009080356, ISSN: 1001-0602 * |
LIN YI ET AL: "Murine CD200(+)CK7(+) trophoblasts in a poly (I : C)-induced embryo resorption model", REPRODUCTION (CAMBRIDGE), vol. 130, no. 4, October 2005 (2005-10-01), pages 529 - 537, XP002443406, ISSN: 1470-1626 * |
PALUDAN CASPER ET AL: "Immune suppression by placenta derived adherent cells (PDAC) correlate with monocyte chemoattractant protein-1 and IL-2 secretion.", BLOOD, vol. 108, no. 11, Part 2, November 2006 (2006-11-01), & SYMPOSIUM OF THE INTERNATIONAL-SOCIETY-OF-MOLECULAR-EVOLUTION; GUANANACASTE, COSTA RICA; JANUARY 08 -12, 2001, pages 48B, XP009084830, ISSN: 0006-4971 * |
YEN B LINJU ET AL: "Isolation of multipotent cells from human term placenta.", STEM CELLS (DAYTON, OHIO) 2005, vol. 23, no. 1, January 2005 (2005-01-01), pages 3 - 9, XP002443187, ISSN: 1066-5099 * |
ZHANG YI ET AL: "Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells", EXPERIMENTAL HEMATOLOGY, NEW YORK, NY, US, vol. 32, no. 7, July 2004 (2004-07-01), pages 657 - 664, XP002389863, ISSN: 0301-472X * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9149569B2 (en) | 2000-12-06 | 2015-10-06 | Anthrogenesis Corporation | Treatment of diseases or disorders using placental stem cells |
US8889411B2 (en) | 2002-04-12 | 2014-11-18 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
US8895256B2 (en) | 2005-10-13 | 2014-11-25 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US9539288B2 (en) | 2005-10-13 | 2017-01-10 | Anthrogenesis Corporation | Immunomodulation using placental stem cells |
US8691217B2 (en) | 2005-12-29 | 2014-04-08 | Anthrogenesis Corporation | Placental stem cell populations |
US9598669B2 (en) | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
US9339520B2 (en) | 2006-10-23 | 2016-05-17 | Anthrogenesis Corporation | Methods and compositions for treatment of bone defects with placental cell populations |
US8916146B2 (en) | 2007-02-12 | 2014-12-23 | Anthrogenesis Corporation | Treatment of inflammatory diseases using placental stem cells |
US9216200B2 (en) | 2007-09-28 | 2015-12-22 | Anthrogenesis Corporation | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
US9255248B2 (en) | 2009-07-02 | 2016-02-09 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
CN101942413B (en) * | 2009-07-07 | 2015-02-11 | 翁炳焕 | Birth defect cell bank and construction method thereof |
CN101942413A (en) * | 2009-07-07 | 2011-01-12 | 翁炳焕 | Birth defect cell bank and construction method thereof |
US9121007B2 (en) | 2010-01-26 | 2015-09-01 | Anthrogenesis Corporatin | Treatment of bone-related cancers using placental stem cells |
US11590173B2 (en) | 2010-02-18 | 2023-02-28 | Osiris Therapeutics, Inc. | Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
US9254302B2 (en) | 2010-04-07 | 2016-02-09 | Anthrogenesis Corporation | Angiogenesis using placental stem cells |
US9464274B2 (en) | 2010-07-13 | 2016-10-11 | Anthrogenesis Corporation | Methods of generating natural killer cells |
US8926964B2 (en) | 2010-07-13 | 2015-01-06 | Anthrogenesis Corporation | Methods of generating natural killer cells |
US8969315B2 (en) | 2010-12-31 | 2015-03-03 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory RNA molecules |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007079183A3 (en) | Placental stem cell populations | |
AU2019268061A1 (en) | Placental stem cell populations | |
WO2006015209A3 (en) | Differentiation of stem cells | |
WO2007047468A3 (en) | Immunomodulation using placental stem cells | |
GB2446525A (en) | Stem cell culture medium and method | |
WO2006070370A3 (en) | Stem cells culture systems | |
WO2005113749A3 (en) | Stem cell populations and methods of use | |
WO2007044418A3 (en) | Cell culture media, kits and methods of use | |
WO2006088867A3 (en) | Method for expansion of stem cells | |
WO2007008758A3 (en) | Methods for identifying agents and conditions that modulate neurogenesis | |
WO2007047766A3 (en) | Methods for rejuvenating cells in vitro and in vivo | |
WO2005021728A3 (en) | Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations | |
WO2008060541A3 (en) | In vitro expansion of postpartum-derived cells using microcarriers | |
WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
WO2004029219A3 (en) | Cell-based rna interference and related methods and compositions | |
WO2005047524A3 (en) | Compositions and methods for inducing cell dedifferentiation | |
WO2007014373A3 (en) | Novel cells, compositions, and methods | |
EP1788073A4 (en) | Porous sheet member for cell culture and, utilizing the same, bioreactor and culturing method | |
WO2007028079A3 (en) | Methods of stimulating expansion of hematopoietic stem cells | |
WO2005089043A3 (en) | Prostate stem cell | |
WO2007100845A3 (en) | Non-embryonic totipotent blastomere-like stem cells and methods therefor | |
WO2007027905A3 (en) | Human renal stem cells | |
WO2007016366A3 (en) | Defined culture conditions of human embryonic stem cells | |
WO2010042551A3 (en) | Methods for providing cellular lysates from cell wall-containing samples | |
WO2006031591A3 (en) | Methods and kits for isolating sperm cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2635253 Country of ref document: CA Ref document number: MX/a/2008/008365 Country of ref document: MX Ref document number: 2006332678 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008548745 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 569562 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2006332678 Country of ref document: AU Date of ref document: 20061228 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087018508 Country of ref document: KR Ref document number: 2006848281 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200680053575.3 Country of ref document: CN |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 223157 Country of ref document: IL Ref document number: 223156 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 223194 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020157020367 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 243876 Country of ref document: IL |